Buy out clauses are another sign the Directors are acting for the management team rather than stockholders. The issue for us is if the big stockholder can force any reforms. If not, and there is not some other deal coming to the table I will be out of here. However the price is low considering analyst projected future earnings so the downside risk of holding now is not bad. I will wait and see what comes out of the annual meeting - as there is definitely upside potential.
focuses on facts, opinions, and ideas. This board seems to focus on personal attacks and unsupported guesses of up or down - with no logic or facts. A little respect for other people would go a long way.
I find this is one of the best of the Yahoo stock discussion boards. People are adding facts, opinions, and ideas while being respectful of others and keeping to topic. What a help it would be if all the Boards were so well utilized.
There was an insider purchase which puts it on some people's "look" list. The look resulted in a few new buyers. In a day or so they will have gone on to other insider-bought stocks. Those who bought will likely hold for several months, as sometimes it takes at least a quarter for insider information to translate into real gains.
Why do you think that will happen? I agree it is fixable. But a poison pill usually means "We don't want it fixed". Worst case someone like Icahn gets some greenmail to go away. Best case is a bidding war won by reformers who act in stockholders interests. So I am holding, for now.
Hard to tell what their holdings are really worth. Difficult to know if management will keep for themselves any big windfall. But there is a small but consistent pattern of insider buying. I will start small and watch for awhile. I think that worst case there is little downside at this price except opportunity cost for a mid to long hold.
Poison pill usually means the Board is looking out for management rather than stockholders interests. Is there any reason to think otherwise here? What do you think the odds are on a bidding war for control that might get the price up to where prospects say it ought to be?
It was hard to get by a lot of $13 sell orders but that has been achieved now so 14 is probably the next hurdle.
But lost less than analyst expected. Future projections are for considerable profit growth I don't believe are reflected in the current price.
Results: Adjusted Earnings Per Share decreased to $-0.41 in the quarter versus EPS of $-0.49 in the year-earlier quarter.
Revenue: Decreased 1.88% to $1.96 billion from the year-earlier quarter.
Actual vs. Wall St. Expectations: TravelCenters of America LLC reported adjusted EPS loss of $0.41 per share. By that measure, the company beat the mean analyst estimate of $-0.43. It missed the average revenue estimate of $2.04 billion.
Good luck with THRM. Looks too rich for me (PE). And I see they have been missing earnings estimates regularly. Or to put it the other way, the analysts on the stock are overly enthused.
� Revenues increased by 58% over the corresponding quarter of fiscal 2011-12
� Gross profit ratio improved to 55% over corresponding quarter's ratio of 48%
� Net income increased to Rs. 287 million compared with Rs. 157 million in corresponding quarter
Historically acquisitions depress stock prices and spin-offs increase them. Each part will probably be priced higher independent from the other, in total. We will see if that happens quickly tomorrow. But it may take awhile for proper valuations to occur.